| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 274,591 | 217,838 | 93,230 | 317,555 |
| Deferred taxes | -9,409 | -759 | 33,683 | 17,465 |
| Depreciation and amortization | 135,441 | 79,724 | 39,148 | 106,905 |
| Stock-based compensation | 141,582 | 93,205 | 44,997 | 134,855 |
| Non-cash operating lease cost | 29,504 | 19,457 | 9,457 | 28,603 |
| Impairment loss on assets held for sale | 23,142 | - | - | - |
| Impairment of equity investment | 85 | - | - | 115 |
| Other non-cash operating activities | -29,349 | -7,593 | -2,950 | -6,931 |
| Accounts receivable | 117,709 | 121,406 | 65,302 | 135,239 |
| Inventories | -3,055 | -9,044 | -7,396 | -32,304 |
| Prepaid expenses and other assets | 4,053 | 22,701 | 21,970 | 26,283 |
| Accounts payable | 6,729 | -7,516 | 8,575 | -13,283 |
| Accrued and other long-term liabilities | -67,730 | -35,503 | -67,877 | 47,618 |
| Long-term income tax payable | 14,130 | 7,092 | 3,316 | -5,186 |
| Deferred revenues | -88,661 | -64,742 | -34,927 | -60,207 |
| Net cash provided by operating activities | 370,046 | 181,326 | 52,676 | 452,153 |
| Acquisitions, net of cash acquired | 0 | 0 | 0 | 77,075 |
| Purchase of property, plant and equipment | 66,529 | 46,768 | 25,289 | 92,619 |
| Purchase of marketable securities | - | - | - | 0 |
| Proceeds from maturities of marketable securities | 0 | 0 | 0 | 25,660 |
| Proceeds from sales of marketable securities | 0 | 0 | 0 | 18,193 |
| Purchase of equity investments | 10,000 | 10,000 | - | 75,390 |
| Other investing activities | 0 | 0 | 0 | -235 |
| Net cash used in investing activities | -76,529 | -56,768 | -25,289 | -200,996 |
| Proceeds from issuance of common stock | 21,749 | 13,909 | 13,909 | 25,281 |
| Common stock repurchases, net of excise tax | 368,691 | 297,134 | 201,088 | 150,012 |
| Activity for equity forward contracts related to accelerated stock repurchase agreements, net | - | - | - | 0 |
| Payroll taxes paid upon the vesting of equity awards | 20,232 | 19,830 | 19,577 | 27,972 |
| Net cash used in financing activities | -367,174 | -303,055 | -206,756 | -152,703 |
| Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | 34,502 | 35,876 | 8,480 | 6,008 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -39,155 | -142,621 | -170,889 | 104,462 |
| Cash and cash equivalents at beginning of period | 1,044,963 | 1,044,963 | 1,044,963 | 938,519 |
| Cash and cash equivalents at end of period | 1,005,808 | 902,342 | 874,074 | 1,042,981 |
ALIGN TECHNOLOGY INC (ALGN)
ALIGN TECHNOLOGY INC (ALGN)